Simona Buelli Selected Research

Simona Buelli Research Topics

Disease

8	Hemolytic-Uremic Syndrome 01/2022 - 12/2006
7	Thrombosis (Thrombus) 01/2022 - 03/2005
6	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 07/2008
4	Inflammation (Inflammations) 03/2024 - 05/2002
4	Diabetic Nephropathies (Diabetic Nephropathy) 12/2020 - 07/2013
4	Thrombocytopenia (Thrombopenia) 01/2019 - 11/2010
4	Hemolytic Anemia 01/2019 - 11/2010
4	Proteinuria 01/2018 - 10/2003
3	Diarrhea 01/2019 - 11/2010
3	Chronic Kidney Failure (Chronic Renal Failure) 07/2013 - 04/2006
2	Kidney Diseases (Kidney Disease) 03/2024 - 01/2011
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 05/2015
2	Colitis 01/2019 - 11/2010
2	Disease Progression 05/2009 - 10/2003
1	Infections 01/2019
1	Chronic Renal Insufficiency 01/2018
1	Immunoglobulin G4-Related Disease 05/2015
1	Cysts 01/2015
1	Insulin Resistance 01/2015
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2015
1	Renal Insufficiency (Renal Failure) 01/2015
1	Neoplasms (Cancer) 03/2014
1	Membranous Glomerulonephritis (Membranous Nephropathy) 08/2011
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 07/2011

Drug/Important Bio-Agent (IBA)

7	Shiga Toxin (Shigella Toxin)IBA 01/2022 - 12/2006
7	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2002
4	Complement System Proteins (Complement)IBA 12/2020 - 03/2005
3	Angiotensin IIIBA 01/2015 - 04/2006
2	Bovine Serum AlbuminIBA 01/2018 - 10/2003
2	AntibodiesIBA 05/2015 - 03/2005
2	Immunoglobulin G (IgG)IBA 05/2015 - 08/2011
2	P-SelectinIBA 07/2011 - 03/2005
1	Complement C3a (Complement 3a)IBA 03/2024
1	AnaphylatoxinsIBA 03/2024
1	Shiga Toxin 2IBA 01/2022
1	globotriaosylceramide (globotriosylceramide)IBA 01/2019
1	ChemokinesIBA 01/2019
1	NF-kappa B (NF-kB)IBA 01/2019
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2018
1	dapagliflozinIBA 01/2018
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2018
1	Endothelin Receptor AntagonistsIBA 01/2016
1	Superoxides (Superoxide)IBA 01/2015
1	bindaritIBA 01/2015
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2015
1	ArrestinIBA 03/2014
1	Endothelin A ReceptorIBA 03/2014
1	Endothelin-1 (Endothelin 1)IBA 03/2014
1	nephrinIBA 07/2013
1	AntigensIBA 08/2011
1	superoxide dismutase 2IBA 08/2011
1	AutoantibodiesIBA 08/2011
1	GlucocorticoidsIBA 07/2011
1	FibrinIBA 07/2011
1	Complement Factor B (Factor B)IBA 07/2011
1	ThrombomodulinIBA 07/2011
1	estropipate (Ogen)FDA LinkGeneric 07/2011
1	Endothelins (Endothelin)IBA 01/2011
1	Complement Factor H (Factor H)IBA 05/2009
1	Virulence Factors (Pathogenicity Factors)IBA 07/2008
1	Shiga Toxins (Vero Toxin)IBA 07/2008
1	AntioxidantsIBA 03/2005
1	Complement Receptors (Complement Receptor)IBA 03/2005
1	LigandsIBA 03/2005
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 03/2005
1	von Willebrand FactorIBA 03/2005
1	Chelating AgentsIBA 03/2005
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2005
1	MetalsIBA 03/2005
1	1,3-dimethylthioureaIBA 03/2005
1	P-selectin ligand proteinIBA 03/2005
1	Integrin alphaVbeta3IBA 03/2005
1	prolinedithiocarbamate (PDTC)IBA 03/2005
1	pyrrolidine dithiocarbamic acidIBA 03/2005
1	Chemokine CX3CL1IBA 10/2003
1	Messenger RNA (mRNA)IBA 10/2003

Therapy/Procedure

3	Therapeutics 01/2018 - 07/2011